Abstract

Extemporaneous Formulations in Pediatric Patients

Author(s): Nahata Milap C

Issue: Jul/Aug 1999 - Compounding Parenteral Products

Page(s): 274-276

Download in electronic PDF format for $75
  • Extemporaneous Formulations in Pediatric Patients Page 1
  • Extemporaneous Formulations in Pediatric Patients Page 2
  • Extemporaneous Formulations in Pediatric Patients Page 3

Abstract

Extemporaneous drug formulations are important in treating pediatric patients, and pharmacists have a unique role in compounding these medicines for use in their patients. The author discusses the need for compounding, required studies for extemporaneous formulations (physicochemical properties, physical and chemical stability, palatability and miscellaneous) and new regulations. A table provides a listing of examples of drugs not available in liquids. The author concludes that joint efforts by various groups are required for making extemporaneous formulations accessible to the most vulnerable populations.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 1999
Pg. 274-276
Author(s): Nahata Milap C
Jan/Feb 2001
Pg. 6-8
Author(s): Preckshot John
Mar/Apr 1997
Pg. 84-86
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 9-12
Author(s): Schotik Debora
Jul/Aug 2019
Pg. 324-331
May/Jun 2007
Pg. 220-225
Jul/Aug 2008
Pg. 372-374
Author(s): Gupta Vishnu D
Jan/Feb 2009
Pg. 14-18
May/Jun 2007
Pg. 259-261
Author(s): Gupta Vishnu D
Nov/Dec 2005
Pg. 456-461
Author(s): Fonseca Simonne C
Jan/Feb 2011
Pg. 78-80
Jan/Feb 2009
Pg. 6-12
Sep/Oct 2009
Pg. 445-446
Author(s): Gupta Vishnu D
Nov/Dec 2005
Pg. 484-486
Author(s): Gupta Vishnu D
Mar/Apr 2005
Pg. 165-166
Nov/Dec 2005
Pg. 437-442
Sep/Oct 2003
Pg. 389-393
May/Jun 2018
Pg. 240-246
Jul/Aug 2022
Pg. 342-351
Sep/Oct 2003
Pg. 386-388
Author(s): Gupta Vishnu D